Targeted delivery of etoposide to osteosarcoma cells using poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles

Yükleniyor...
Küçük Resim

Tarih

2017

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

TÜBİTAK

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Folic acid (FA)-functionalized poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles were prepared to enhance the delivery efficiency of the anticancer drug etoposide for the clinical treatment of osteosarcoma. PHBV nanoparticles were synthesized by emulsification/solvent evaporation technique and obtained in the size range of 200–250 nm and zeta potential range of –21 and –27 mV. Encapsulation efficiency and in vitro drug release were studied. The cytotoxic, apoptotic, and necrotic effects of PHBV nanoparticles were also investigated using Saos-2 osteosarcoma cells. The results obtained in this study demonstrate that etoposideloaded and FA-functionalized PHBV nanoparticles can be successfully used for targeted treatment of osteosarcoma.
...

Açıklama

Tamer Çırak (Aksaray, Yazar)

Anahtar Kelimeler

PHBV Nanoparticle, Folate Targeting, Etoposide, Targeted Drug Delivery, Osteosarcoma, ...

Kaynak

Turkish Journal of Biology

WoS Q Değeri

N/A

Scopus Q Değeri

Q1

Cilt

41

Sayı

5

Künye